Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg
Allopurinol prevents or lowers high uric acid levels caused by cancer medicines or in patients with kidney stones
Three factors to make a next-gen eCOA platform work
Melissa Mooney, Director, eCOA Solutions Engineering, IQVIA, emphasises that as timelines tighten, regulatory scrutiny…
Venus Remedies secures Ukrainian GMP renewal
The certification applies to the company's Unit-II manufacturing facility located in Baddi, Himachal Pradesh, covering its…
Biocon Biologics gains contract extension for Insulins supply by Malaysian MoH
The amendment to the contract will be formalised through the execution of a formal supplementary agreement between the MoH, DMktg…
Real-world data backs anti-IL-5 use in COPD with comorbid asthma
GlobalData’s latest analysis highlights the results of a retrospective study from Ghent University Hospital based on Belgian…
GS1 General Assembly 2025 was hosted in Mumbai by GS1 India
The gathering brings together global leaders, innovators, and delegates on a shared mission of data integrity and collaboration
Senores Pharmaceuticals gains ANDA for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from…
Enalapril is indicated as a treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction
Hillchol: Bharat Biotech’s oral cholera vaccine demonstrates success in phase III clinical studies
Hillchol has demonstrated against both Ogawa and Inaba serotypes, and aims to address the global shortage of cholera vaccines
Symbiosis completes MHRA audit of new sterile Fill/Finish Facility
The inspection assessed the company’s new purpose-built Bruce Building, a 20,000 sq ft aseptic facility
Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan
Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA)